Bessemer Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35K Sell
539
-163
-23% -$11.5K ﹤0.01% 1775
2025
Q4
$47K Buy
702
+158
+29% +$10.6K ﹤0.01% 1656
2025
Q3
$40K Hold
544
﹤0.01% 1496
2025
Q2
$28K Buy
544
+8
+1% +$455 ﹤0.01% 1468
2025
Q1
$34K Buy
536
+207
+63% +$12K ﹤0.01% 1384
2024
Q4
$16K Sell
329
-60
-15% -$3.08K ﹤0.01% 1592
2024
Q3
$22K Buy
389
+87
+29% +$4.99K ﹤0.01% 1483
2024
Q2
$16K Buy
302
+191
+172% +$8.38K ﹤0.01% 1420
2024
Q1
$5K Sell
111
-100
-47% -$3.75K ﹤0.01% 1708
2023
Q4
$8K Hold
211
﹤0.01% 1635
2023
Q3
$8K Sell
211
-596
-74% -$24.4K ﹤0.01% 1630
2023
Q2
$29K Buy
807
+634
+366% +$21.6K ﹤0.01% 1463
2023
Q1
$6K Sell
173
-4,418
-96% -$207K ﹤0.01% 1571
2022
Q4
$262K Buy
4,591
+4,449
+3,133% +$228K ﹤0.01% 840
2022
Q3
$6K Buy
+142
New +$6.28K ﹤0.01% 1656
2022
Q1
Sell
-330
Closed -$13K 1867
2021
Q4
$13K Hold
330
﹤0.01% 1359
2021
Q3
$13K Hold
330
﹤0.01% 1312
2021
Q2
$15K Sell
330
-430
-57% -$19K ﹤0.01% 1271
2021
Q1
$32K Sell
760
-140
-16% -$6.39K ﹤0.01% 1098
2020
Q4
$38K Sell
900
-400
-31% -$14.4K ﹤0.01% 1040
2020
Q3
$34K Sell
1,300
-700
-35% -$19.5K ﹤0.01% 977
2020
Q2
$54K Buy
+2,000
New +$45.1K ﹤0.01% 1331
2018
Q2
Sell
-19,172
Closed -$376K 1721
2018
Q1
$376K Hold
19,172
﹤0.01% 871
2017
Q4
$388K Buy
+19,172
New +$352K ﹤0.01% 874

Other funds holding HALO

Bessemer Group's HALO Position: Q1 2026 in Review

Bessemer Group reduced its Halozyme (HALO) stake by 23% in Q1 2026, selling an estimated $11.5K and leaving 539 shares worth $35K. The position accounts for ﹤0.01% of the portfolio, ranked #1775.

Bessemer Group first reported a position in HALO in Q4 2017 and has held it in 24 quarters since. The position peaked at $388K in Q4 2017. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Bessemer Group held 539 shares of Halozyme worth $35K as of Q1 2026.
  • Bessemer Group sold 163 Halozyme shares in Q1 2026, an estimated $11.5K.
  • Halozyme made up ﹤0.01% of Bessemer Group's portfolio in Q1 2026, its #1775 holding.
  • Bessemer Group first reported a position in Halozyme in Q4 2017 and has held it in 24 quarters since.
  • Bessemer Group's Halozyme position peaked at $388K in Q4 2017.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.